Enhancer ID: | E_01_0470 |
Species: | human |
Position : | chrX:123856883-123858883 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | -- |
Pubmed ID: | 29772677 |
Enhancer experiment: | Western Blot,Co-Immunoprecipitation,Cell Cycle Analysis,Crystal Violet Assay,Cytotoxicity Assay,flow cytometry |
Enhancer experiment description: | Overall, these findings suggest that lambertianic acid enhances TRAIL-induced apoptosis via inhibition of XIAP/NF-?B in TRAIL resistant NSCLCs. |
Target gene : | -- |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | Overall, these findings suggest that lambertianic acid enhances TRAIL-induced apoptosis via inhibition of XIAP/NF-?B in TRAIL resistant NSCLCs. |
TF name : | XIAP |
TF experiment: | Western Blot,Co-Immunoprecipitation,Cell Cycle Analysis,Crystal Violet Assay,Cytotoxicity Assay,flow cytometry |
TF experiment description: | Overall, these findings suggest that lambertianic acid enhances TRAIL-induced apoptosis via inhibition of XIAP/NF-?B in TRAIL resistant NSCLCs. |
Enhancer function : | Overall, these findings suggest that lambertianic acid enhances TRAIL-induced apoptosis via inhibition of XIAP/NF-?B in TRAIL resistant NSCLCs. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
Overall, these findings suggest that lambertianic acid enhances TRAIL-induced apoptosis via inhibition of XIAP/NF-?B in TRAIL resistant NSCLCs. |
SNP ID: | -- |